Blog

Synlogic (SYBX) versus Baxalta (BXLT) Head to Head Contrast – Week Herald

Synlogic (SYBX) versus Baxalta (BXLT) Head to Head Contrast
Week Herald
The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on

and more »

2018-02-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.